• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMERIEUX SA VIDAS FSH 60 TESTS; VIDAS® FSH 60 TESTS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMERIEUX SA VIDAS FSH 60 TESTS; VIDAS® FSH 60 TESTS Back to Search Results
Catalog Number 30407
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Patient Involvement (2645)
Event Type  malfunction  
Event Description
Note: reference 30407 is not registered in the united states.The u.S.Similar device is product reference (b)(4).A customer in (b)(6) notified biomérieux of obtaining an out range result for an external instand quality control sample in association with the vidas® fsh 60 tests (ref 30407, batch 1007759040).The customer obtained a result of 2.72 iu/l, this was below the specified range of 2.8 ¿ 4.3 iu/l.As there is no patient associated with this quality control sample, there is no adverse event related to any patient's state of health.Biomérieux has initiated an internal investigation.
 
Manufacturer Narrative
This report was initially submitted following notification from a customer in germany regarding out-of-range-low (oorl) results for an eqa sample (instand sample 32 group 297) in association with the vidas fsh assay (ref.30407, lot 1007759040).Sample 32: peer group = 3.55 ui / l acceptable range [2.80-4.30] ui/l; customer's result = 2.72 ui / l out of the acceptable range.A biomérieux investigation was conducted; however, the customer did not submit any sample for testing.Evaluation of manufacturing batch records indicated no anomaly during the stages of manufacture, control and packaging.Analysis of several internal serum sera on seven (7) lots of vidas fsh ref.30407, including customer lot, indicated the lot was in specification and in the trend with the other lots.Investigational testing of the implicated lot with internal samples and two (2) samples of probioqual showed all results obtained comply with the expected and targeted standards.The lot has not drifted since its release.The anomaly was not reproduced.The issue reported by the customer (low results for sample 32 external quality control instand) was not reproduced by complaints laboratory with sample available in the laboratory.Without the customer's return sample, further investigation and determination of root cause is not possible.The investigation concluded the kit vidas fsh ref.30407; batch 1007759040 / 201113-0 is within the expected performance.There are no other complaints for eqa control out of range results on this vidas batch.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VIDAS FSH 60 TESTS
Type of Device
VIDAS® FSH 60 TESTS
Manufacturer (Section D)
BIOMERIEUX SA
chemin de l orme
marcy l etoile 69280
FR  69280
MDR Report Key10402285
MDR Text Key204009251
Report Number8020790-2020-00074
Device Sequence Number1
Product Code CGJ
Combination Product (y/n)N
PMA/PMN Number
K921746
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 09/21/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/13/2020
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/13/2020
Device Catalogue Number30407
Device Lot Number1007759040
Was Device Available for Evaluation? No
Date Manufacturer Received08/27/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-